Columbus Circle Investors’s Evolent Health EVH Stock Holding History

Columbus Circle Investors’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,126,608	Closed	-$22.5M	–	159
2018 Q4	$22.5M	Sell	1,126,608 -78,397	-7%	-$1.81M	0.64%	68
2018 Q3	$34.2M	Buy	1,205,005 +567,543	+89%	+$13.5M	0.68%	55
2018 Q2	$13.4M	Buy	+637,462	New	+$12.1M	0.28%	122
2017 Q4	–	Sell	-193,249	Closed	-$3.44M	–	206
2017 Q3	$3.44M	Buy	193,249 +43,949	+29%	+$906K	0.06%	188
2017 Q2	$3.79M	Buy	+149,300	New	+$3.59M	0.06%	175

Other funds holding EVH

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Columbus Circle Investors's EVH Position: Q1 2019 in Review

Columbus Circle Investors sold out of Evolent Health (EVH) in Q1 2019, closing a stake of 1,126,608 shares — an estimated $22.5M sold.

Columbus Circle Investors first reported a position in EVH in Q2 2017 and held it in 5 quarters. The position peaked at $34.2M in Q3 2018. 192 funds tracked by Wall St. Rank hold EVH as of Q1 2019.

Columbus Circle Investors reported no remaining Evolent Health position as of Q1 2019 after selling out during the quarter.
Columbus Circle Investors sold 1,126,608 Evolent Health shares in Q1 2019, an estimated $22.5M.
Columbus Circle Investors first reported a position in Evolent Health in Q2 2017 and held it in 5 quarters.
Columbus Circle Investors's Evolent Health position peaked at $34.2M in Q3 2018.
192 funds tracked by Wall St. Rank held Evolent Health as of Q1 2019.

Based on Columbus Circle Investors's 13F filing for Q1 2019, filed 22 Apr 2019.